Key Highlights

  • Callan JMB (NASDAQ:CJMB) advanced 12.42% to USD 0.3946, following an announcement about a QuickStrip production line.
  • Rockwell Medical (NASDAQ:RMTI) gained 11.04% to USD 7.67 after it agreed to take over parts of Vantive's hemodialysis business.
  • Change Agents (NASDAQ:CHGA) increased 8.76% to USD 0.97 after joining Meta's Muse Developer Program.
  • Braiin (NASDAQ:BRAI) climbed 10.40% to USD 2.76, with no announcement identified.
  • Primech Holdings (NASDAQ:PMEC) rose 11.12% to USD 0.3637, with no announcement identified.

Callan JMB (NASDAQ:CJMB) (up USD 0.0436, 12.42%): A Thin-Film Production Line Arrives

Callan JMB (NASDAQ:CJMB) rose 12.42% to USD 0.3946 in pre-market trading on November 3, 2026. On November 2, 2026, the company said it received a complete QuickStrip oral thin-film production line from Rapid Dose Therapeutics for its Texas facility.

Management said the platform could produce up to USD 15 million in Revenue during its first 18 months, but only if the equipment is successfully qualified. The release gave no installation timeline, equipment cost or margins. As a Penny Stock under USD 1, it can be volatile, thinly traded and exposed to dilution risk.

Rockwell Medical (NASDAQ:RMTI) (up USD 0.7626, 11.04%): A Dialysis Agreement

Rockwell Medical (NASDAQ:RMTI) gained 11.04% to USD 7.67 in pre-market trading on November 3, 2026. A definitive agreement with Vantive covers the purchase of its hemodialysis concentrates, monitors and water treatment systems, plus the Medolla, Italy plant. Dialyzers, including Theranova, are excluded.

Closing is expected in mid-2027, subject to regulatory approvals. Price and financing terms were not disclosed, and cash and investments stood at USD 24.8 million on June 30, 2026, so funding remains an open question and share issuance could dilute holders. The company reports third quarter results on November 12, 2026.

Change Agents (NASDAQ:CHGA) (up USD 0.0781, 8.76%): Entering Meta's Muse Program

Change Agents (NASDAQ:CHGA) rose 8.76% to USD 0.97 in pre-market trading on November 3, 2026. A November 2, 2026 release said it has joined the Muse Developer Program operated by Meta Platforms (NASDAQ:META), a move toward linking its Catch-Up and Beacon applications to Muse.

The company described this as an initial step, with any integration subject to development, testing and approval. It regained Nasdaq minimum bid compliance on September 15, 2026 after a 1-for-20 reverse split, yet the price is back under USD 1.00. Third-party data lists a float near 794,000 shares, which can amplify volatility.

Braiin (NASDAQ:BRAI) (up USD 0.2600, 10.40%): A Bounce Without a New Headline

Braiin (NASDAQ:BRAI) climbed 10.40% to USD 2.76 in pre-market trading on November 3, 2026, implying a prior close near USD 2.50 (calculated). No company announcement dated November 2 or November 3, 2026 was identified.

The latest catalyst is the October 26, 2026 expansion of its RADIUS platform with Force AI. Shares remain far below the 50-day average of USD 4.91. A financial news item indicated the company postponed its Annual Report because financial statements were incomplete, a point to verify in its filings. As a penny stock, price swings can be wide.

Primech Holdings (NASDAQ:PMEC) (up USD 0.0364, 11.12%): Robot Contract Makes the News

Primech Holdings (NASDAQ:PMEC) rose 11.12% to USD 0.3637 in pre-market trading on November 3, 2026. No company release dated November 2 or 3, 2026 was identified, so the catalyst is not confirmed.

On October 29, 2026, the company announced a contract worth over USD 60,000 for one HYTRON restroom-cleaning robot and four years of maintenance at a Singapore mall. Robotics revenue was only about USD 12,000 in the fiscal year ended March 31, 2026. Trading under USD 1 adds risk, including dilution from Equity issuance.

Overall View

The five names share a pre-market gain but not a common cause. Callan JMB and Rockwell Medical have news dated this week, Change Agents is reacting to a program announcement from the previous session, and Braiin and Primech Holdings have no identified announcement. Items to watch include whether gains hold once regular trading opens, Rockwell Medical's purchase price and financing details, qualification of the QuickStrip line and any customer data from Beacon or Force AI.